Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma

Final draft guidance

Final draft guidance (PDF 273 KB)

Committee papers (PDF 2.25 MB)

Public committee slides (PDF 647 KB)

Draft guidance

Committee papers (PDF 9.64 MB)

Appraisal consultation document (PDF version) (PDF 307 KB)

Appraisal consultation document (online commenting)

Public committee slides (PDF 1.61 MB)

Committee meeting: 2

Final scope (PDF 207 KB)

Final stakeholder list (PDF 167 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 157 KB)

Equality impact assessment (Scoping) (PDF 127 KB)

Draft matrix post referral (PDF 164 KB)